bpc 157 more plates more dates Inside the confusing, scary world of injectable peptides BPC-157 in Miami: Cost, Legality
Description
Year plan 220 Six injections over 12 months for ongoing maintenance
doi: 10.1016/J.SOARD.2017.11.010
This remains an actively moving area, however: on February 27, 2026, the HHS Secretary publicly announced an intent to move roughly 14 of the 19 Category 2-listed peptides, reportedly including ipamorelin and CJC-1295, back toward Category 1 status, and multiple industry and legal-news outlets reported further FDA action in the following months easing Category 2-related restrictions on this group of peptides
doi: 10.1016/0893-133X(95)00079-S
